Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Medical Genetics

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmg.40.12.e131PMID 14684699PMCID PMC1735331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Germline 657del5 mutation in the NBS1 gene in breast cancer patients

  2003cited by this paper
• Nibrin Forkhead-associated Domain and Breast Cancer C-terminal Domain Are Both Required for Nuclear Focus Formation and Phosphorylation*

  2003cited by this paper
• Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells

  2002cited by this paper
• Functional analysis of FHA and BRCT domains of NBS1 in chromatin association and DNA damage responses.

  2002cited by this paper
• Cancer predisposition and hematopoietic failure in Rad50 mice

  2002cited by this paper
• Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest

  2002cited by this paper
• The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Cancer predisposition and hematopoietic failure in Rad50(S/S) mice.

  2002cited by this paper
• CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q.

  2002cited by this paper
• The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling

  2002cited by this paper
• An update on conformation sensitive gel electrophoresis

  2002cited by this paper
• Tethering on the brink: the evolutionarily conserved Mre11-Rad50 complex.

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• CANCER BIOLOGY: Enhanced: A Matter of Dosage

  2002cited by this paper
• A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

  2002cited by this paper
• Polygenic susceptibility to breast cancer and implications for prevention

  2002cited by this paper
• Cancer biology. A matter of dosage.

  2002cited by this paper
• The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50[middle dot]hMRE11[middle dot]NBS1 complex DNA repair activity.

  2001cited by this paper
• Chk2 Activation Dependence on Nbs1 after DNA Damage

  2001cited by this paper
• Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).

  2001cited by this paper
• Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice.

  2001cited by this paper
• Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase.

  2001cited by this paper
• Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

  2001cited by this paper
• An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele

  2001cited by this paper
• hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay.

  2001cited by this paper
• Distinct Functional Domains of Nibrin Mediate Mre11 Binding, Focus Formation, and Nuclear Localization

  2001cited by this paper
• "Other" breast cancer susceptibility genes: searching for more holy grail.

  2001cited by this paper
• Mutation analysis of the CHK2 gene in families with hereditary breast cancer

  2001cited by this paper
• Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres

  2000cited by this paper
• The Forkhead-associated Domain of NBS1 Is Essential for Nuclear Foci Formation after Irradiation but Not Essential for hRAD50·hMRE11·NBS1 Complex DNA Repair Activity*

  2000cited by this paper
• Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products

  2000cited by this paper
• Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily.

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response.

  1999cited by this paper
• The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.

  1999cited by this paper
• The Nijmegen Breakage Syndrome Protein Is Essential for Mre11 Phosphorylation upon DNA Damage*

  1999cited by this paper
• Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation.

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Molecular genetics of the Finnish disease heritage.

  1999cited by this paper
• Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

  1998cited by this paper
• Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.

  1998cited by this paper
• The genetics of breast cancer susceptibility.

  1998cited by this paper
• Alteration of N-terminal phosphoesterase signature motifs inactivates Saccharomyces cerevisiae Mre11.

  1998cited by this paper
• The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.

  1998cited by this paper
• Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

  1997cited by this paper
• Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart.

  1997cited by this paper
• A low proportion of BRCA2 mutations in Finnish breast cancer families.

  1997cited by this paper
• Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells.

  1997cited by this paper
• Human Rad50 is physically associated with human Mre11: identification of a conserved multiprotein complex implicated in recombinational DNA repair

  1996cited by this paper

• Bioinformatics Based Drug Repurposing Approach for Breast and Gynecological Cancers: RECQL4/FAM13C Genes Address Common Hub Genes and Drugs

  2025cites this paper
• Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing

  2025cites this paper
• Genomic instability in ovarian cancer: Through the lens of single nucleotide polymorphisms.

  2024cites this paper
• Germline pathogenic variants in the MRE11, RAD50, and NBN (MRN) genes in cancer predisposition: A systematic review and meta‐analysis

  2024cites this paper
• The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population

  2023cites this paper
• Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases

  2023cites this paper
• Essential role of the BRCA2B gene in somatic homologous recombination in Arabidopsis thaliana

  2023cites this paper
• Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients

  2022cites this paper
• An in-silico analysis to identify structural, functional and regulatory role of SNPs in hMRE11

  2022influential citation
• Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

  2022cites this paper
• Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy

  2022cites this paper
• Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2

  2022cites this paper
• Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair

  2021cites this paper
• Yeast-based screening of cancer mutations in the DNA damage response protein Mre11 demonstrates importance of conserved capping domain residues

  2021cites this paper
• Homologous recombination deficiency: cancer predispositions and treatment implications.

  2021cites this paper
• MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy.

  2021cites this paper
• Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study

  2020cites this paper
• Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients

  2020cites this paper
• Lack of Replication Disruption Following H2O2-induced damage in Escherichia coli.

  2020influential citation
• A Survey of Reported Disease-Related Mutations in the MRE11-RAD50-NBS1 Complex

  2020cites this paper
• DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

  2020cites this paper
• Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes

  2020cites this paper
• Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

  2020cites this paper
• Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population

  2020cites this paper
• Hereditary ovarian cancers: state of the art.

  2019cites this paper
• Personalised Medicine

  2019cites this paper
• DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies.

  2019cites this paper
• Protein Expression of DNA Damage Signaling Molecules in Patients with Oral Squamous Cell Carcinoma

  2018cites this paper
• Hereditary predisposition to breast cancer : evaluating the role of rare copy number variant, protein-truncating and missense candidate alleles

  2018cites this paper
• Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics

  2018cites this paper
• Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.

  2018cites this paper
• Genomic analysis of DNA repair genes and androgen signaling in prostate cancer

  2018cites this paper
• DNA damage repair in ovarian cancer: unlocking the heterogeneity

  2018cites this paper
• Computational Modelling of Human Transcriptional Regulation by an Information Theory-based Approach

  2018cites this paper
• RAD50 germline mutations are associated with poor survival in BRCA1/2–negative breast cancer patients

  2018cites this paper
• Personalised Medicine: Genome Maintenance Lessons Learned from Studies in Yeast as a Model Organism.

  2017cites this paper
• Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer

  2017cites this paper
• Studies of lncRNAs in DNA double strand break repair: what is new?

  2017cites this paper
• Evaluation of the association between common genetic variants and breast cancer risk

  2017cites this paper
• Breast cancer genetics in young women: What do we know?

  2017cites this paper
• Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type–Specific Differences

  2017cites this paper
• Hereditary Gynecologic Cancer Predisposition Syndromes

  2017cites this paper
• Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.

  2017cites this paper
• Genomic and Transcriptomic Investigation of Endemic Burkitt Lymphoma and Epstein Barr Virus

  2017cites this paper
• Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer

  2017cites this paper
• Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.

  2016influential citation
• Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel

  2016cites this paper
• Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.

  2016cites this paper
• Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

  2016cites this paper
• Mining for novel tumor suppressor genes using a shortest path approach

  2016cites this paper
• Prioritizing variants in complete Hereditary Breast and Ovarian Cancer (HBOC) genes in patients lacking known BRCA mutations

  2016cites this paper
• SYNTHETIC LETHALITY OF CDK INHIBITION AND DOXORUBICIN IN TRIPLE-NEGATIVE BREAST CANCER REQUIRES P53 INACTIVATION

  2015cites this paper
• Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes

  2015cites this paper
• DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.

  2015cites this paper
• Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.

  2015cites this paper
• Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer

  2015cites this paper
• Hereditary breast cancer syndromes and genetic testing

  2015cites this paper
• Characterization of MRE11 Mutants Provides Insight into Human Genetic Disease, Cancer, and Clinical Intervention.

  2015cites this paper
• Identification of genetic markers that predict cancer sensitivity to the anticancer drugs 5-FU and Irinotecan

  2015influential citation
• Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.

  2015cites this paper
• Beyond BRCA: new hereditary breast cancer susceptibility genes.

  2015cites this paper
• RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy

  2014cites this paper
• Next-Generation Sequencing for Inherited Breast Cancer Risk: Counseling through the Complexity

  2014cites this paper
• Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study

  2014cites this paper
• Hereditary predisposition to breast cancer – with a focus on AATF , MRG15 , PALB2 , and three Fanconi anaemia genes

  2014cites this paper
• The MRE11 complex: an important source of stress relief.

  2014cites this paper
• Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’

  2014cites this paper
• Analiza molekularna kompleksu genów MRE11/RAD50/NBS1 w rodzinach z agregacją zachorowań na raki piersi i/lub jajnika

  2014cites this paper
• Expanding the genetic basis of copy number variation in familial breast cancer

  2014cites this paper
• Growing recognition of the role for rare missense substitutions in breast cancer susceptibility.

  2014cites this paper
• RAD50:n merkitys perinnöllisessä rintasyöpäalttiudessa

  2014cites this paper
• PALB2 and RAP80 genes in hereditary breast cancer predisposition

  2013cites this paper
• Breast cancer genes: beyond BRCA1 and BRCA2.

  2013cites this paper
• The MRN protein complex genes : MRE 11 and RAD 50 and susceptibility to head and neck cancers

  2013influential citation
• Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia

  2013cites this paper
• Hereditary Breast Cancer: The Era of New Susceptibility Genes

  2013cites this paper
• The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers

  2013influential citation
• The contribution of recurrent BRCA2 mutations in unselected French Canadian ovarian cancer cases

  2013cites this paper
• Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer

  2013cites this paper
• DNA repair dysregulation from cancer driver to therapeutic target

  2012cites this paper
• Mutation screening of RAD51C in high-risk breast and ovarian cancer families

  2012cites this paper
• Cancer predisposing BARD1 mutations in breast-ovarian cancer families

  2012cites this paper
• Defective homologous recombination in human cancers.

  2012cites this paper
• The improvement of breast cancer prognosis accuracy from integrated gene expression and clinical data

  2012cites this paper
• High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

  2012cites this paper
• BRCA1 requirement for the fidelity of plasmid DNA double‐strand break repair in cultured breast epithelial cells

  2012cites this paper
• Cancer predisposing BARD1 mutations in breast–ovarian cancer families

  2011cites this paper
• BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer

  2011cites this paper
• Analyse des variants de séquence et d'épissage du gène FANCC chez les familles canadiennes-françaises à risque élevé pour le cancer du sein et/ou de l'ovaire

  2011cites this paper
• Crystal structure of human Mre11: understanding tumorigenic mutations.

  2011cites this paper
• RAD50 gene mutations are not likely a risk factor for breast cancer in Poland

  2010cites this paper
• Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.

  2010cites this paper
• Discovering moderate-risk breast cancer susceptibility genes.

  2010cites this paper
• Analysis of the expression of human tumor antigens in ovarian cancer tissues

  2009cites this paper
• Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function

  2009cites this paper
• Rad50 c.687delT Does Not Contribute Significantly to Familial Breast Cancer in a French Population

  2009influential citation
• Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line

  2009cites this paper
• Other Hereditary Breast Cancer Syndromes and Genes

  2009cites this paper
• Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

  2009cites this paper
• CLSPN AND PALB 2 GENES IN FAMILIAL BREAST CANCER SUSCEPTIBILITY

  2008cites this paper